Subiaco, Australia

Anthony Bosco

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anthony Bosco: Innovator in Immunotherapy Drug Combinations

Introduction

Anthony Bosco is a notable inventor based in Subiaco, Australia. He has made significant contributions to the field of immunotherapy through his innovative research and development. His work focuses on enhancing the effectiveness of drug combinations in treating malignant conditions.

Latest Patents

Anthony Bosco holds a patent for a method titled "Method for the identification of immunotherapy-drug combinations using a network approach." This invention relates to systems and methods for evaluating the differentiality of a set of discrete random variables between two or more conditions. Specifically, it addresses the response of a malignant condition to a treatment regime compared to one that does not respond. The patent also provides a framework for identifying and selecting drugs that work in a coordinated manner to mimic a genetic network of a malignant condition that responds to immune checkpoint blockade agents. He has 1 patent to his name.

Career Highlights

Anthony is affiliated with The University of Western Australia, where he continues to advance his research in immunotherapy. His work is pivotal in understanding how different drug combinations can be optimized for better patient outcomes.

Collaborations

Some of his notable coworkers include Willem Joost Lesterhuis and Richard Andrew Lake. Their collaborative efforts contribute to the ongoing research and development in the field of immunotherapy.

Conclusion

Anthony Bosco's innovative approach to identifying effective immunotherapy-drug combinations marks a significant advancement in cancer treatment. His contributions are vital for the future of personalized medicine and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…